NEW YORK, Jan. 20, 2017 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dollar General Corporation (“Dollar General” or the “Company”) (NYSE:DG) of the March 20, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
The lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of all those who purchased Dollar General stock or options between March 10, 2016 and November 30, 2016 (the “Class Period”). The case, Iron Worker Local Union No. 405 Annuity Fund v. Dollar General Corporation et al, No. 17-cv-00063 was filed on January 18, 2017, and has been assigned to Judge Kevin H. Sharp.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to appropriately disclose how announced limitations on Supplemental Nutrition Assistance Program (“SNAP”) benefits would have a material impact on the Company's financial performance.
Initially, on August 25, 2016, the Company announced disappointing second quarter 2016 financial and operational results caused by “a reduction in both SNAP participation rates and benefit levels.” After the announcement, Dollar General’s share price fell from $91.79 per share on August 24, 2016 to a closing price of $75.61 on August 25, 2016 —a $16.18 or a 17.63% drop.
Then, on December 1, 2016, Dollar General announced third quarter 2016 financial and operational results that included a reduction in same-store sales. The Company cited reductions in SNAP benefits as a major contributor of the disappointing results, and admitted that the benefit reductions “affect[] about 56% of our store base . . . And those states that have had the reduction or elimination, they are approximately 100-basis-point worse in comp. That gives you a real good idea of how impactful those SNAP benefits reductions have been.” After the announcement, Dollar General’s share price fell from $77.32 per share on November 30, 2016 to a closing price of $73.48 on December 1, 2016—a $3.84 or a 4.97% drop.
Request more information now by clicking here: www.faruqilaw.com/DG. There is no cost or obligation to you.
Take Action
If you invested in Dollar General stock or options between March 10, 2016 and November 30, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/DG. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Dollar General’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Italy Fines Apple €98.6 Million Over App Store Dominance
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



